Extracellular inhibitors can attenuate tumorigenic Wnt pathway activity in adenomatous polyposis coli mutants: Predictions of a validated mathematical model

Open Access

Peer-reviewed

Research Article

Gili Hochman,

Affiliation Institute for Medical BioMathematics, Bene Ataroth, Israel

http://orcid.org/0000-0003-0265-5943

⨯
Karin Halevi-Tobias,

Affiliation Institute for Medical BioMathematics, Bene Ataroth, Israel
⨯
Yuri Kogan,

Affiliation Institute for Medical BioMathematics, Bene Ataroth, Israel
⨯
Zvia Agur

* E-mail: agur@imbm.org

Affiliation Institute for Medical BioMathematics, Bene Ataroth, Israel
⨯

Reader Comments (0)

Antigen-presenting cells
Is the Subject Area "Antigen-presenting cells" applicable to this article?

Thanks for your feedback.
Dose prediction methods
Is the Subject Area "Dose prediction methods" applicable to this article?

Thanks for your feedback.
Mutation
Is the Subject Area "Mutation" applicable to this article?

Thanks for your feedback.
Colorectal cancer
Is the Subject Area "Colorectal cancer" applicable to this article?

Thanks for your feedback.
Mathematical models
Is the Subject Area "Mathematical models" applicable to this article?

Thanks for your feedback.
Biochemical simulations
Is the Subject Area "Biochemical simulations" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Tumor suppressor genes
Is the Subject Area "Tumor suppressor genes" applicable to this article?

Thanks for your feedback.